Key result
Older age linked to higher epidural analgesia levels and prolonged bupivacaine half-life.
Why the study?
Effects of aging on epidural administration of 0.5% bupivacaine without epinephrine were studied to understand age-related pharmacodynamic and pharmacokinetic changes.
Does age affect the pharmacodynamics and pharmacokinetics of epidural bupivacaine?
Observational
Does age affect the pharmacodynamics and pharmacokinetics of epidural bupivacaine?
Aging alters the pharmacokinetics and spread of epidural bupivacaine, with decreased clearance and increased terminal half-life in older patients.
Answers are grounded in this paper and cite their sources.
Age increases cephalad spread and slows bupivacaine clearance after epidural; leaves open whether dose reduction improves safety in elderly patients.
Effects of aging after epidural administration of 0.5% bupivacaine without epinephrine were studied in two groups of patients, between 20 and 55 yr old and older than 55 yr, respectively. All patients received 95 mg bupivacaine HCl. The onset of analgesia in caudad segments decreased with age and the upper level of analgesia increased with age. Effects of age on duration of anesthesia could not be demonstrated. The total plasma clearance of bupivacaine decreased and the terminal half-life increased with age. Age had no effect on the peak plasma concentrations and time to peak concentrations.
No takes yet. Share an insight, caveat, or question.
Veering et al. (1987) reported an observational. Older age (>55 years) vs. Age 20 to 55 years was evaluated on Onset and upper level of analgesia, duration of anesthesia, and pharmacokinetics. Older age (>55 years) decreased the onset of analgesia in caudad segments, increased the upper level of analgesia, decreased total plasma clearance, and increased terminal half-life.
Synapse has enriched 10 related papers. Consider them for comparative context: